Retinalamin

Retinalamin is described in the supplied guide as a peptide-based bioregulator obtained from retinal tissue. The guide associates it with research into retinal maintenance and visual function, but the supplied material does not establish therapeutic benefit.

The retina contains specialized neural cells that convert light into signals used for vision. Retinal injury and degeneration can impair this process, providing a biological rationale for investigating approaches to cellular preservation and repair.

The guide proposes effects on retinal cellular repair, neuronal preservation, and inflammatory processes. It does not identify specific molecular interactions or provide experimental findings that establish these mechanisms.

1. 01

   Molecular target

2. 02

   Cellular signal

3. 03

   Biological process

LEVEL 01 · Basic biology

A biological mechanism or molecular interaction is described. No claim about human outcomes.

Evidence levels reflect the state of documented research only. They are not rankings of popularity, quality or suitability, and a higher level never implies that a compound is an approved medicine.

The source guide presents Retinalamin as a compound intended to preserve retinal function and encourage tissue recovery. It links the compound to age-associated visual decline and diabetes-related retinal damage, while suggesting that it may slow deterioration. The guide also characterizes tolerability favorably, but supplies no identifiable clinical references in these notes.

Source: The Complete Guide to Peptides: Unlocking the Secrets to Health, Healing and Longevity — Hack Smith, Chapter 7, Introduction to Bioregulators (page references not verified)

Summarised in our own wording from the cited reference. The reference is a popular guide, not peer-reviewed literature; its statements are reported here as source claims rather than established facts.

Dosage, reconstitution and administration guidance is deliberately excluded from this platform.

The preparation's precise composition, mechanism, and strength of supporting evidence cannot be determined from the supplied material. Claims of retinal regeneration, improved sight, or reduced progression require verification against primary research.

Safety data are limited in the supplied material, and the guide's favorable characterization does not establish a comprehensive safety profile. It mentions transient visual changes, but neither their frequency nor the proposed explanation is substantiated by the notes. This information is not medical advice.

Research-stage compound unless otherwise established by a competent authority. Regulatory classification differs between jurisdictions and can change over time; nothing here indicates marketing authorisation.

Primary reference for this entry:

The Complete Guide to Peptides: Unlocking the Secrets to Health, Healing and Longevity — Hack Smith, Chapter 7, Introduction to Bioregulators (page references not verified)

Suggested literature search terms taken from the source. They are search starting points, not citations to specific studies.

• “Retinalamin retinal regeneration”
• “Retinalamin for vision improvement”
• “Retinalamin peptide for macular degeneration”

Editorial status

source reviewed

Last updated

2026-09-14

Last reviewed

2026-09-13

Language

EN